List of works - Lee Albacker

A pan-cancer landscape of telomeric content shows that RAD21 and HGF alterations are associated with longer telomeres

scientific article published on 26 February 2022

Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden

scientific article published on 19 September 2017

Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma

scientific article

Emergence of novel and dominant acquired EGFR solvent-front mutations at Gly796 (G796S/R) together with C797S/R and L792F/H mutations in one EGFR (L858R/T790M) NSCLC patient who progressed on osimertinib

scientific article published on 12 April 2017

Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies

scientific article

High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis

scientific article

Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity.

scientific article

Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.

scientific article published on 25 November 2011

Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion

scientific article published on 9 November 2017

Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC

scientific article published in PLoS ONE

Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma

scientific article published on 17 May 2018

Mutations in the TERC template sequence can be incorporated into the telomeres of human tumors

Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response

scientific article published on 30 October 2020

Synthesis of fungal glycolipid asperamide B and investigation of its ability to stimulate natural killer T cells

scientific article

TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells.

scientific article

TIM-4, expressed by medullary macrophages, regulates respiratory tolerance by mediating phagocytosis of antigen-specific T cells

scientific article

The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy

scientific article published on 09 August 2019

The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors

scientific article published on 06 May 2020

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

scientific article

List of works by Lee Albacker

A pan-cancer landscape of telomeric content shows that RAD21 and HGF alterations are associated with longer telomeres

Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden

Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma

Emergence of novel and dominant acquired EGFR solvent-front mutations at Gly796 (G796S/R) together with C797S/R and L792F/H mutations in one EGFR (L858R/T790M) NSCLC patient who progressed on osimertinib

Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies

High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis

Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity.

Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity.

Loss of function JAK1 mutations occur at high frequency in cancers with microsatellite instability and are suggestive of immune evasion

Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC

Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma

Mutations in the TERC template sequence can be incorporated into the telomeres of human tumors

Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response

Synthesis of fungal glycolipid asperamide B and investigation of its ability to stimulate natural killer T cells

TIM-4, a receptor for phosphatidylserine, controls adaptive immunity by regulating the removal of antigen-specific T cells.

TIM-4, expressed by medullary macrophages, regulates respiratory tolerance by mediating phagocytosis of antigen-specific T cells

The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy

The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors

Tissue expression of PD-L1 mediates peripheral T cell tolerance.